CRS + HIPEC combined with IP + IV chemotherapy for gastric signet-ring cell carcinoma: Case report of long-term survival

RATIONALE: Signet ring cell carcinoma of the stomach is prone to relapse and metastasis after traditional surgical treatment, and the prognosis is also poor. We improved the concept of treatment and conducted cytoreductive surgery (CRS) plus hyperthermic intraperitoneal chemotherapy (HIPEC) combined...

Täydet tiedot

Bibliografiset tiedot
Päätekijät: Yan, Guo-Jun, Ji, Zhong-He, Liu, Gang, Li, Yan
Aineistotyyppi: Online Artikkeli Teksti
Kieli:English
Julkaistu: Lippincott Williams & Wilkins 2020
Aiheet:
4500
Linkit:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544424/
https://www.ncbi.nlm.nih.gov/pubmed/33031325
http://dx.doi.org/10.1097/MD.0000000000022647

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7544424/
https://www.ncbi.nlm.nih.gov/pubmed/33031325
http://dx.doi.org/10.1097/MD.0000000000022647

Samankaltaisia teoksia